Doxorubicin News and Research

RSS
Doxorubicin hydrochloride is approved for use with other drugs as adjuvant therapy for breast cancer that has spread to the lymph nodes, including cancer that is HER-2 positive or has spread after surgery.

In addition to the uses that have been approved by the FDA, doxorubicin hydrochloride is sometimes used alone or with other drugs to treat other types of cancer. The drug continues to be studied in the treatment of many types of cancer.
Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems

Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems

Race is associated with unfavorable breast cancer tumor biology

Race is associated with unfavorable breast cancer tumor biology

Photochemistry creates drug-trapping nanoparticles

Photochemistry creates drug-trapping nanoparticles

Temperature-sensitive nanoparticle boosts drug antitumor activity

Temperature-sensitive nanoparticle boosts drug antitumor activity

In vitro assessment of transferrin-conjugated liposomes as drug delivery systems for inhalation therapy of lung cancer

In vitro assessment of transferrin-conjugated liposomes as drug delivery systems for inhalation therapy of lung cancer

Researchers identify potential ovarian cancer stem cells

Researchers identify potential ovarian cancer stem cells

Study indicates heart damage from some cancer drugs worsens over the years

Study indicates heart damage from some cancer drugs worsens over the years

New polymer-lipid hybrid nanoparticle

New polymer-lipid hybrid nanoparticle

Promising chemo, therapeutic viruses, cutting-edge surgery debut at M. D. Anderson Cancer Center

Promising chemo, therapeutic viruses, cutting-edge surgery debut at M. D. Anderson Cancer Center

Polymer-based therapy for breast cancer

Polymer-based therapy for breast cancer

Benefit of chemotherapy in breast cancer depends on estrogen status of tumors

Benefit of chemotherapy in breast cancer depends on estrogen status of tumors

Biodegradable drug containing nano-particles effective in killing human breast tumors

Biodegradable drug containing nano-particles effective in killing human breast tumors

Combination therapy improves Acquired Immunodeficiency Syndrome-Related Lymphoma outcome

Combination therapy improves Acquired Immunodeficiency Syndrome-Related Lymphoma outcome

Study identifies compounds that overcome a specific type of resistance to chemotherapeutic-induced apoptosis

Study identifies compounds that overcome a specific type of resistance to chemotherapeutic-induced apoptosis

Breast ducts - A new site for cancer treatment!

Breast ducts - A new site for cancer treatment!

DOS47 scientific paper published in the Journal of Experimental Therapeutics and Oncology

DOS47 scientific paper published in the Journal of Experimental Therapeutics and Oncology

New treatment advances for patients with follicular lymphoma

New treatment advances for patients with follicular lymphoma

Rev/Dex combo looks like a breakthrough treatment for multiple myeloma

Rev/Dex combo looks like a breakthrough treatment for multiple myeloma

Complex chemotherapy cocktails offers pluses, minuses in advanced endometrial cancer

Complex chemotherapy cocktails offers pluses, minuses in advanced endometrial cancer

Bone marrow may be source of new egg-cell generation

Bone marrow may be source of new egg-cell generation